TY - JOUR
T1 - Epidemiology and management of infectious complications in contemporary management of chronic leukemias
AU - Young, Jo Anne H.
PY - 2011/1/1
Y1 - 2011/1/1
N2 - This is a review of the epidemiology and management of infectious complications in contemporary management of chronic leukemias. Patients with chronic leukemias typically are affected by nuisance infections due to the underlying hematologic condition, particularly hypogammaglobulinemia in CLL patients. With active treatment, particularly those agents that cause defects in cell-mediated immunity, the incidence of opportunistic infections increases although endogenous bacterial, mycobacterial, and fungal infections also occur. Exogenous treatment with immunoglobulin and antimicrobial prophylaxis, particularly anti-Pneumocystis prophylaxis, may be indicated in select patients. Routine vaccinations should be maintained in these patients and vaccination early in the course of treatment may result in improve protection.
AB - This is a review of the epidemiology and management of infectious complications in contemporary management of chronic leukemias. Patients with chronic leukemias typically are affected by nuisance infections due to the underlying hematologic condition, particularly hypogammaglobulinemia in CLL patients. With active treatment, particularly those agents that cause defects in cell-mediated immunity, the incidence of opportunistic infections increases although endogenous bacterial, mycobacterial, and fungal infections also occur. Exogenous treatment with immunoglobulin and antimicrobial prophylaxis, particularly anti-Pneumocystis prophylaxis, may be indicated in select patients. Routine vaccinations should be maintained in these patients and vaccination early in the course of treatment may result in improve protection.
KW - Chronic granulocytic leukemia (CGL)
KW - Chronic lymphoid leukemia (CLL)
KW - Chronic myelogenous leukemia (CML)
KW - Hypogammaglobulinemia
KW - Opportunistic infection
KW - Pneumocystis
UR - http://www.scopus.com/inward/record.url?scp=79551623826&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79551623826&partnerID=8YFLogxK
U2 - 10.2174/187152611794407755
DO - 10.2174/187152611794407755
M3 - Article
C2 - 21303335
AN - SCOPUS:79551623826
VL - 11
SP - 3
EP - 10
JO - Infectious Disorders - Drug Targets
JF - Infectious Disorders - Drug Targets
SN - 1871-5265
IS - 1
ER -